Nanocarriers as treatment modalities for hypertension-Reference-Cited by-同舟云学术

Nanocarriers as treatment modalities for hypertension

Published:2017-01-01 Issue:1 Volume:24 Page:358-369
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Alam Tausif¹,Khan Saba¹,Gaba Bharti¹,Haider Md. Faheem¹,Baboota Sanjula¹,Ali Javed¹

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/10717544.2016.1255999

Reference90 articles.

1. ACE 2 Modulator [Online]. Available at: http://www.apeiron-biologics.com [last accessed 14 Apr 2016]

2. Adis Insight [Online]. Available at: http://adisinsight.springer.com/drugs/800003008 [last accessed 12 Apr 2016]

3. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine

4. Ambrisentan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) [Online]. (2016). Available at: www.reuters.com [last accessed 11 Apr 2016]

5. Aldosterone Synthase Inhibition in Hypertension

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on nanocarriers as a targeted delivery system for the treatment of breast cancer;Intelligent Pharmacy;2024-06

2. A Comprehensive Review on Nanoparticles as Drug Delivery System and Their Role for Management of Hypertension;Current Pharmaceutical Biotechnology;2024-04-02

3. siRNA as potential therapeutic strategy for hypertension;European Journal of Pharmacology;2024-04

4. Chronomodulated drug delivery systems for the treatment of hypertension: An overview;Intelligent Pharmacy;2024-02

5. Nanoparticle-Based Therapies in Hypertension;Hypertension;2023-12